Has anyone done a bit of reading on the above mentioned adaptive platform trial?
I see they are finishing up the current trial and plan to launch a new, better one soon. The new trial will be in collaboration with the Global Coalition for Adaptive Research (GCAR).
For anyone not familiar with adaptive platform trials, they are usually phase 2/3 trials with rolling addition of new cohorts of novel therapies as they get accepted into the trial. Usually a single control group to benchmark against all the other cohorts.
Saves heaps time and money for companies developing novel therapies.
https://pancan.org/research/precision-promise/
Has anyone done a bit of reading on the above mentioned adaptive...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $43.96M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $26.86K | 164.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16700 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 57284 | 2 |
View Market Depth
| Last trade - 15.46pm 11/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |